Año: 2021
Journal Impact Factor (JIF): 6.8830
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 57/245 | Q1 | T1 | D3 |
Año: 2021
Journal Citation Indicator (JCI): 0,950
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 92/318 | Q2 | T1 | D3 | 71,23 |
Año:
2021
CiteScore:
6,600
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Oncology | 94/360 | Q2 | T1 | D3 |
| Cancer Research | 89/210 | Q2 | T2 | D5 |
SJR año:
2021
Factor de Impacto:
1,524
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Oncology | 57/404 | Q1 | T1 | D2 |
| Cancer Research | 49/238 | Q1 | T1 | D3 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) | |
| 2 | Miah, A. B. | The Institute of Cancer Research, London (United Kingdom) |
| 3 | Frezza, A. M. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 4 | Messiou, C. | The Institute of Cancer Research, London (United Kingdom) |
| 5 | Morosi, C. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 6 | Caraceni, A. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 7 | Antonescu, C. R. | Weill Cornell Medicine (United States) |
| 8 | Bajpai, J. | Homi Bhabha National Institute (India) |
| 9 | Baldini, E. | Brigham and Women's Hospital (United States) |
| 10 | Bauer, S. | Universitäts Klinikum Essen und Medizinische Fakultät (Germany) |
| 11 | Biagini, R. | IRCCS Regina Elena National Cancer Institute (Italy) |
| 12 | Bielack, S. | Klinikum Stuttgart Olgahospital (Germany) |
| 13 | Blay, J. Y. | Université Claude Bernard Lyon 1 (France) |
| 14 | Bonvalot, S. | Université PSL (France) |
| 15 | Boukovinas, I. | Sin datos () |
| 16 | Bovee, J. V.M.G. | Leiden University Medical Center - LUMC (Netherlands) |
| 17 | Boye, K. | Rikshospitalet-Radiumhospitalet HF (Norway) |
| 18 | Brodowicz, T. | Medizinische Universitat Wien (Austria) |
| 19 | Callegaro, D. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 20 | Álava, E. de | Hospital Universitario Virgen del Rocío (Spain) |
| 21 | Deoras-Sutliff, M. | EHE Foundation (United States) |
| 22 | Dufresne, A. | Université Claude Bernard Lyon 1 (France) |
| 23 | Eriksson, M. | Skånes universitetssjukhus (Sweden) |
| 24 | Errani, C. | IRCCS Rizzoli Orthopaedic Institute, Bologna (Italy) |
| 25 | Fedenko, A. | P. A. Hertsen Moscow Oncology Research Center (Russian Federation) |
| 26 | Ferraresi, V. | IRCCS Regina Elena National Cancer Institute (Italy) |
| 27 | Ferrari, A. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 28 | Fletcher, C. D.M. | Brigham and Women's Hospital (United States) |
| 29 | García del Muro, X. | Institute Catala Oncologia (Spain) |
| 30 | Gelderblom, H. | Leiden University Medical Center - LUMC (Netherlands) |
| 31 | Gladdy, R. A. | University of Toronto (Canada) |
| 32 | Gouin, F. | Le Centre Régional de Lutte Contre le Cancer Léon Bérard (France) |
| 33 | Grignani, G. | Candiolo Cancer Institute-FPO- IRCCS (Italy) |
| 34 | Gutkovich, J. | NYU Langone Health (United States) |
| 35 | Haas, R. | The Netherlands Cancer Institute (Netherlands) |
| 36 | Hindi, N. | Universidad de Sevilla (Spain) |
| 37 | Hohenberger, P. | Universitätsklinikum Heidelberg (Germany) |
| 38 | Huang, P. | The Institute of Cancer Research, London (United Kingdom) |
| 39 | Joensuu, H. | Helsinki University Hospital (Finland) |
| 40 | Jones, R. L. | The Institute of Cancer Research, London (United Kingdom) |
| 41 | Jungels, C. | Institut Jules Bordet (Belgium) |
| 42 | Kasper, B. | Universitätsklinikum Mannheim (Germany) |
| 43 | Kawai, A. | National Cancer Center Hospital (Japan) |
| 44 | Le Cesne, A. | Stabilité génétique et oncogenèse (France) |
| 45 | Le Grange, F. | University College London Hospitals NHS Foundation Trust (United Kingdom) |
| 46 | Leithner, A. | Medizinische Universität Graz (Austria) |
| 47 | Leonard, H. | Charity number 1162472 (None) |
| 48 | López Pousa, A. | Hospital de La Santa Creu I Sant Pau (Spain) |
| 49 | Martín Broto, J. | Hospital Universitario Fundación Jiménez Díaz (Spain) |
| 50 | Merimsky, O. | Tel Aviv University, Sackler Faculty of Medicine (Israel) |
| 51 | Merriam, P. | Dana-Farber Cancer Institute (United States) |
| 52 | Miceli, R. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 53 | Mir, O. | Stabilité génétique et oncogenèse (France) |
| 54 | Molinari, M. | University of Pittsburgh Medical Center (United States) |
| 55 | Montemurro, M. | Centre Hospitalier Universitaire Vaudois (Switzerland) |
| 56 | Oldani, G. | Hôpitaux universitaires de Genève (Switzerland) |
| 57 | Palmerini, E. | IRCCS Rizzoli Orthopaedic Institute, Bologna (Italy) |
| 58 | Pantaleo, M. A. | Institute of Oncology (Italy) |
| 59 | Patel, S. | University of Texas MD Anderson Cancer Center (United States) |
| 60 | Piperno-Neumann, S. | Institut Curie (France) |
| 61 | Raut, C. P. | Brigham and Women's Hospital (United States) |
| 62 | Ravi, V. | University of Texas MD Anderson Cancer Center (United States) |
| 63 | Razak, A. R.A. | University of Toronto Faculty of Medicine (Canada) |
| 64 | Reichardt, P. | Helios Klinikum Berlin-Buch (Germany) |
| 65 | Rubin, B. P. | Cleveland Clinic Foundation (United States) |
| 66 | Rutkowski, P. | Maria Sklodowska-Curie Institute – Oncology Center (Poland) |
| 67 | Safwat, A. A. | Aarhus Universitetshospital (Denmark) |
| 68 | Sangalli, C. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 69 | Sapisochin, G. | University of Toronto (Canada) |
| 70 | Sbaraglia, M. | Sin datos () |
| 71 | Scheipl, S. | Medizinische Universität Graz (Austria) |
| 72 | Schöffski, P. | Leuvens Kankerinstituut (Belgium) |
| 73 | Strauss, D. | The Institute of Cancer Research, London (United Kingdom) |
| 74 | Strauss, S. J. | University College London Hospitals NHS Foundation Trust (United Kingdom) |
| 75 | Sundby Hall, K. | Rikshospitalet-Radiumhospitalet HF (Norway) |
| 76 | Tap, W. D. | Weill Cornell Medicine (United States) |
| 77 | Trama, A. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 78 | Tweddle, A. | Royal Marsden Hospital, London (United Kingdom) |
| 79 | van der Graaf, W. T.A. | The Netherlands Cancer Institute (Netherlands) |
| 80 | Van De Sande, M. A.J. | Leiden University Medical Center - LUMC (Netherlands) |
| 81 | Van Houdt, W. | The Netherlands Cancer Institute (Netherlands) |
| 82 | van Oortmerssen, G. | Leiden University (Netherlands) |
| 83 | Wagner, A. J. | Dana-Farber Cancer Institute (United States) |
| 84 | Wartenberg, M. | Sarcoma Patients EuroNet (SPAEN) (Germany) |
| 85 | Wood, J. | Royal Marsden NHS Foundation Trust (United Kingdom) |
| 86 | Zaffaroni, N. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 87 | Zimmermann, C. | University of Toronto (Canada) |
| 88 | Casali, P. G. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 89 | Dei Tos, A. P. | Sin datos () |
| 90 | Gronchi, A. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
